PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
Get Alerts PKI Hot Sheet
Join SI Premium – FREE
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 8:45 a.m. ET.
Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview on the Company and its strategic priorities during a fireside chat at this year’s virtual conference. To register, click here.
A live audio webcast will be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $5.0 billion in 2021, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005080/en/
Investor Relations:
Steve Willoughby
(781) 663-5677
[email protected]
Media Relations:
Chet Murray
(781) 663-5728
[email protected]
Source: PerkinElmer, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
- Anthony Espo Builds The Bad Ass Academy Mindset
- Off Market Acquisitions Modernizes Business Deals
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share